ASGE Annual GI Advanced Practice Provider Course - Day One | July 2021-Presentation 7 - Management of Anti-Thrombotic Agents for Patients Undergoing GI Endoscopy

Presentation 7 - Management of Anti-Thrombotic Agents for Patients Undergoing GI Endoscopy

Video Transcription

Video Summary

In this video, Dr. Vivek Kahl discusses the management of antithrombotic agents for patients undergoing GI endoscopy. He emphasizes that the paradigm has shifted to prioritize saving the myocardium and preventing strokes over GI bleeding and endoscopy. Dr. Kahl reviews the bleeding risk associated with different endoscopic procedures and risk stratifies thrombotic conditions in patients. He also discusses the various anticoagulant and antiplatelet agents and their mechanisms of action. Dr. Kahl emphasizes the importance of balancing the risk and benefit of inducing or managing GI bleeding around endoscopic procedures versus the thromboembolic risk. He provides guidelines for the management of anticoagulants and antiplatelet agents pre and post-procedure. Dr. Kahl also discusses difficult scenarios such as Jehovah's Witness patients or patients with acute MI who are on antithrombotics and need endoscopic procedures. He stresses the importance of a patient-centered multidisciplinary approach and communication between team members to ensure patient safety and minimize liability. Overall, Dr. Kahl highlights the need for individualized patient care based on the specific procedure and patient risk factors.

Asset Subtitle

Vivek Kaul, MD, FASGE

Keywords

antithrombotic agents

GI endoscopy

myocardium

GI bleeding

risk stratification

anticoagulant agents

thromboembolic risk